Charles Schwab Investment Management Inc 89bio, Inc. Put Options Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ETNB
# of Institutions
164Shares Held
89.1MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$95.8 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$56.1 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$50.4 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$47.9 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$42.1 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $353M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...